Islets of Langerhans Transplantation: Clinical Trials

36 trials of Islets of Langerhans Transplantation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

20 completed, 5 unknown, 4 active not recruiting, 4 terminated. 16 Phase 2, 14 Phase 1, 6 Phase 3, 4 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 216Completed 11, Active not recruiting 2, Terminated 2, Recruiting 1
Phase 114Completed 6, Terminated 3, Active not recruiting 2, Recruiting 1, Unknown 1, Withdrawn 1
Phase 36Completed 3, Active not recruiting 1, Unknown 1, Withdrawn 1
Not applicable4Unknown 3, Completed 1

Follow Islets of Langerhans Transplantation: new trials by email Literature Review of Islets of Langerhans Transplantation trials Research Report on Islets of Langerhans Transplantation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Breakthrough - T1DM and Chronic Kidney Disease
Tegoprubart, Islet Cell Transplant - Diabete Type 1, Chronic Kidney Disease
Phase 1 / Phase 2RecruitingUniversity of Chicago102027-04-292026-08-20
Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)
Islet transplantation with Tegoprubart (AT-1501) immunosupression-based therapy - Type 1 Diabetes Mellitus
Phase 1 / Phase 2Active not recruitingUniversity of Chicago702024-03-042026-09-22
Novel Method of Pancreatic Islet Transplantation Into the Omentum
Pancreatic islet transplantation - Islets of Langerhans Transplantation
Not applicableUnknownFrantisek Saudek62019-08-152021-08-31
Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant
Alpha 1-Antitrypsin, Islet Transplantation, Thymoglobulin - Kidney Transplant, Type 1 Diabetes
Phase 2CompletedMassachusetts General Hospital22017-01-012023-12-22
Health Economic Analysis of Islet Cell Transplantation for the Stabilization of the Severe Forms of Type 1 Diabetes
Islet graft, best medical care - Type 1 Diabetes
Phase 3UnknownUniversity Hospital, Grenoble422016-07-072022-06-24
Pancreatic Islet Transplantation in the Anterior Chamber of the Human Eye - a Pilot Study
Pancreatic islet transplantation in the anterior chamber - Type 1 Diabetes Mellitus
Not applicableUnknownUniversity Hospital, Basel, Switzerland42016-03-012024-03-29
Islet Cell Transplant for Type 1 Diabetes
Allogenic Human Islet Cells, Immunosuppressive Agents, Gastrin 17 - Type 1 Diabetes Mellitus
Phase 2Active not recruitingCity of Hope Medical Center102015-07-102026-10-26
Nephrologic Prognosis 10 Years After Diabetes Cell Therapy
islet transplanted, non islet transplanted - Islet Transplantation
CompletedUniversity Hospital, Lille452014-11-032022-04-29
Allogeneic Islet Cells Transplanted Onto the Omentum
Islet transplantation - Type 1 Diabetes Mellitus, Hypoglycemia
Phase 1 / Phase 2CompletedRodolfo Alejandro32014-09-012025-08-12
A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients
Islet Cell Transplant - Type 1 Diabetes, Severe Hypoglycemic Unawareness
Phase 3CompletedNorthwestern University102012-06-012026-06-18
A Comparison of Islet Cell Transplantation With Medical Therapy for the Treatment of Diabetic Eye Disease
islet cell transplant, Medical therapy - Diabetic Retinopathy, Diabetic Macular Edema
Phase 3WithdrawnUniversity of British Columbia2009-12-012014-03-17
Islet After Kidney Transplantation (IAK) in Patients With Type 1 Diabetes
Islet Transplantation, Islet cell transplantation - Diabetes Mellitus
Phase 1CompletedCity of Hope Medical Center32008-10-182026-04-27
Pancreatic Islet Cell Transplantation After Kidney Transplantation - A Novel Approach to Immunosupression
Islet cell transplantation - Islet Cell Transplantation, Type 1 Diabetes
Phase 1WithdrawnBaylor Research Institute2008-07-012017-02-15
Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment
Islet cell transplantation - Islet Cell Transplantation, Type 1 Diabetes
Phase 1CompletedBaylor Research Institute12008-07-012017-04-24
Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol
Islets of Langerhans transplantation - Type 1 Diabetes Mellitus
Phase 3Active not recruitingCellTrans Inc.212007-09-052026-04-06
Efficacy of Islet After Kidney Transplantation
Islet transplantation, Antithymocyte Globulin, Daclizumab or Basiliximab - Type 1 Diabetes Mellitus
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)242007-01-012017-10-20
UVA Islet Cell Transplantation in Patients With Type I Diabetes
Pancreatic Islets of Langerhans Cell Transplant - Diabetes Mellitus, Type 1
Phase 1UnknownUniversity of Virginia202007-01-012009-02-18
Islet Transplantation in Type 1 Diabetes
Allogeneic Pancreatic Islet Cells, Antithymocyte Globulin, Sirolimus - Type 1 Diabetes Mellitus
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)482006-10-012019-07-17
Steroid-free and Long-term Calcineurin-free Trial in Islet Cell Transplantation
Islet transplantation - Type 1 Diabetes Mellitus
Phase 2CompletedRodolfo Alejandro32005-07-012017-05-25
Islet of Langerhans Graft Monitoring by Magnetic Resonance Imaging
ferucarbotran (iron-based MRI contrast agent), Islet transplantation, Magnetic resonance imaging - Type 1 Diabetes Mellitus
Phase 1TerminatedUniversity Hospital, Geneva52005-06-012014-12-02

Showing 20 of 36. Sign in to see all of them.

Conditions studied

Diabetes Mellitus, Type 1 (30)  ·  Diabetes Mellitus (12)  ·  Hypoglycemia (10)  ·  Hyperglycemia (3)  ·  Autoimmune Diseases (2)  ·  Diabetic Retinopathy (1)  ·  Metabolic Diseases (1)  ·  Renal Insufficiency, Chronic (1)

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (4)  ·  Rodolfo Alejandro (4)  ·  Baylor Research Institute (3)  ·  City of Hope Medical Center (3)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (3)  ·  University Hospital, Lille (3)  ·  University of Chicago (2)  ·  CellTrans Inc. (1)  ·  Frantisek Saudek (1)  ·  Massachusetts General Hospital (1)  ·  National Center for Research Resources (NCRR) (1)  ·  Northwestern University (1)  ·  University Hospital, Basel, Switzerland (1)  ·  University Hospital, Geneva (1)  ·  University Hospital, Grenoble (1)

Countries

United States (27)  ·  France (4)  ·  Switzerland (4)  ·  Canada (3)  ·  Czechia (1)  ·  Germany (1)  ·  Italy (1)

Top investigators

Rodolfo Alejandro, M.D. (3)  ·  Rodolfo Alejandro, MD (3)  ·  Fouad Kandeel, MD (2)  ·  James Shapiro, MD, PhD (2)  ·  Jose Oberholzer, MD (2)  ·  Ali Naji, PhD (1)  ·  Andrew Posselt, MD, PhD (1)  ·  Bernhard Hering, MD (1)  ·  Camillo Ricordi, M.D. (1)  ·  Camillo Ricordi, MD (1)  ·  Daniel Borja-Cacho, MD (1)  ·  David M. Thompson, MD (1)  ·  Fouad Kandeel, MD, PhD (1)  ·  Francois Pattou, MD (1)

Results publications

PMID 19005394, PMID 20003758, PMID 22996144, PMID 23438305, PMID 25393157, PMID 28941330, PMID 31615852, PMID 39780302, PMID 15257060, PMID 15996257, PMID 17005949, PMID 18360260, PMID 18444920, PMID 19104407, PMID 19418039, PMID 19638525, PMID 20660050, PMID 23630300, PMID 25629445, PMID 27208344, PMID 27465220, PMID 28219959, PMID 29506054, PMID 29563196, PMID 29654388, PMID 29779835, PMID 39735417, PMID 39881535

NIH funding

M01RR000036 (1), R01DK025802 (1), R01DK055347 (1), R01DK056953 (1), U42RR016603 (1)